USE OF CERULOPLASMIN LEVELS TO MONITOR RESPONSE TO THERAPY AND PREDICT RECURRENCE OF BREAST-CANCER

被引：23

作者：

SCHAPIRA, DV ^{[1
]}

SCHAPIRA, M ^{[1
]}

机构：

[1] UNIV SASKATCHEWAN HOSP,SASKATOON CANC CLIN,SASKATOON S7N 0W8,SASKATCHEWAN,CANADA

来源：

关键词：

D O I：

10.1007/BF01803564

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：221 / 224

页数：4

共 10 条

[1] DIONIGI P, 1981, EUR SURG RES, V13, P31
[2] HRGOVCIC M, 1968, CANCER, V21, P743, DOI 10.1002/1097-0142(196804)21:4<743::AID-CNCR2820210427>3.0.CO
[3] 2-A
[4] LINDER MC, 1981, JNCI-J NATL CANCER I, V67, P263
[5] PLASMA CERULOPLASMIN - EVIDENCE FOR ITS PRESENCE IN AND UPTAKE BY HEART AND OTHER ORGANS OF RAT
LINDER, MC
MOOR, JR
[J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1977, 499 (03) : 329 - 336
[6] LINDER MC, 1979, COMPENDIUM ASSAYS IM, P311
[7] MAILER C, 1979, CANCER RES, V34, P637
[8] ONIZUKA K, 1979, RINSHO MENEKI, V11, P285
[9] RAJU K, 1982, P AM ASSOC CANC RES, V23, P43
[10] SCHAPIRA M, 1972, J ROY COLL GEN PRACT, V22, P384